Literature DB >> 22449791

Successful pregnancy and delivery after concomitant temozolomide and radiotherapy treatment of glioblastoma multiforme.

J McGrane, T Bedford, S Kelly.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22449791     DOI： 10.1016/j.clon.2012.01.005

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN： 0936-6555            Impact factor:   4.126


× No keyword cloud information.
  6 in total

1.  Effect of temozolomide on male gametes: an epigenetic risk to the offspring?

Authors:  I Berthaut; D Montjean; L Dessolle; K Morcel; F Deluen; C Poirot; A Bashamboo; K McElreavey; C Ravel
Journal:  J Assist Reprod Genet       Date:  2013-05-08       Impact factor: 3.412

2.  Pregnancy and glial brain tumors.

Authors:  Shlomit Yust-Katz; John F de Groot; Diane Liu; Jimin Wu; Ying Yuan; Mark D Anderson; Charles A Conrad; Andrea Milbourne; Mark R Gilbert; Terri S Armstrong
Journal:  Neuro Oncol       Date:  2014-03-09       Impact factor: 12.300

3.  Fetal radiation monitoring and dose minimization during intensity modulated radiation therapy for glioblastoma in pregnancy.

Authors:  David P Horowitz; Tony J C Wang; Cheng-Shie Wuu; Wenzheng Feng; Daphnie Drassinower; Anita Lasala; Radoslaw Pieniazek; Simon Cheng; Eileen P Connolly; Andrew B Lassman
Journal:  J Neurooncol       Date:  2014-08-06       Impact factor: 4.130

Review 4.  Pregnancy in women with gliomas: a case-series and review of the literature.

Authors:  Hanneke Zwinkels; Joep Dörr; Fred Kloet; Martin J B Taphoorn; Charles J Vecht
Journal:  J Neurooncol       Date:  2013-08-25       Impact factor: 4.130

5.  Case Report: Pregnancy in a patient with recurrent glioblastoma.

Authors:  Birgit Flechl; Marco Ronald Hassler; Gerhard Kopetzky; Peter Balcke; Christine Kurz; Christine Marosi
Journal:  F1000Res       Date:  2013-11-15

6.  Advanced case of glioblastoma multiforme and pregnancy. An ethical dilemma.

Authors:  Intisar M Al-Rasheedy; Fahad M Al-Hameed
Journal:  Neurosciences (Riyadh)       Date:  2015-10       Impact factor: 0.906
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.